SEC Form 4 · accession 0001104659-15-002656

Radius Health, Inc. · RDUS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Morana Jovan-Embiricos

Director · 10% Owner

Period of report

Jul 10, 2014

Accepted (ET)

Jan 15, 2015 · 5:03 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001428522

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2	Jul 10, 2014	J	251,680	—	D	335,820	I	By Fund
Common Stock^F1,F2	Jul 15, 2014	J	335,820	—	D	0	I	By Fund
Common Stock^F3	holding	—	—		—	1,167,997	I	By Fund
Common Stock^F4	holding	—	—		—	1,794,983	I	By Fund
Common Stock^F5	holding	—	—		—	871,851	I	By Fund

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

F1Reflects a distribution by F2 Bioscience VI L.P. ("F2 Bioscience VI") to a limited partner.
F2The reported securities are owned directly by F2 Bioscience VI. F2 Bioscience IV GP Ltd. is the General Partner of F2 Bioscience VI. The members of F2 Bioscience IV GP Ltd are Katherine Priestley and Globeways Holdings Limited. The reporting person is a beneficial owner of Globeways Holdings Limited. The reporting person disclaims beneficial ownership of the securities reported herein except to the extent of her pecuniary interest therein.
F3The reported securities are owned directly by F2 Bioscience III L.P. ("F2 Bioscience III"). F2 Biosciences GP Ltd. ("F2 GP") is the General Partner of F2 Bioscience III. The members of F2 GP are Katherine Priestley and Globeways Holdings Limited. The reporting person is a beneficial owner of Globalways Holdings Limited. The reporting person disclaims beneficial ownership of the securities reported herein except to the extent of her pecuniary interest therein.
F4The reported securities are owned directly by F2 Bioscience IV L.P. ("F2 Bioscience IV"). F2 Bioscience IV GP Ltd. is the General Partner of F2 Bioscience IV. The members of F2 Bioscience IV GP Ltd are Katherine Priestley and Globeways Holdings Limited. The reporting person is a beneficial owner of Globeways Holdings Limited. The reporting person disclaims beneficial ownership of the securities reported herein except to the extent of her pecuniary interest therein.
F5The reported securities are owned directly by F2 Bio Ventures V L.P. ("F2 Bio"). F2 Bio Ventures GP Ltd is General Partner of F2 Bio. The sole member of F2 Bio Ventures GP Ltd is Globeways Holdings Limited. The reporting person is a beneficial owner of Globeways Holdings Limited. The reporting person disclaims beneficial ownership of the securities reported herein except to the extent of her pecuniary interest therein.